Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adopting a Precision Medicine Paradigm in Puerto Rico: Leveraging Ancestral Diversity to Identify Predictors of Clopidogrel Response in Caribbean Hispanics

NCT03419325 is registered in ClinicalTrials.gov with University of Puerto Rico as lead sponsor.

NCT NCT03419325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03419325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adopting a Precision Medicine Paradigm in Puerto Rico: Leveraging Ancestral Diversity to Identify Predictors of Clopidogrel Response in Caribbean Hispanics
Lead sponsor
University of Puerto Rico
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2020
Completion date
December 30, 2025
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, cardiovascular disease (cvd), coronary artery disease, myocardial infarction, peripheral arterial disease, stroke